Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression

Journal of Psychiatric Research

Volumn 34, Issue 3, 2000, Pages 183-186

  Ströhle, Andreas ^a   Pasini, Augusto ^b   Romeo, Elena ^b   Hermann, Bettina ^a   Spalletta, Gianfranco ^b   Di Michele, Flavia ^c   Holsboer, Florian ^a   Rupprecht, Rainer ^a,d  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antidepressants; Depression; Fluoxetine; Neuroactive steroids; Neurosteroids; THDOC; THP

Indexed keywords

FLUOXETINE; NEUROSTEROID; TETRAHYDRODEOXYCORTICOSTERONE; TETRAHYDROPROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DESOXYCORTICOSTERONE; FLUOXETINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MULTIVARIATE ANALYSIS; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS;

EID: 0343294328     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(00)00006-6     Document Type: Article

References (18)

1. Celotti F., Melcangi R.C., Martini L. The 5α-reductase in the brain: molecular aspects and relation to brain function. Front Neuroendocrin. 13:1992;163-215.
2. Corpéchot C., Young J., Calvel M., Wehrey C., Veltz J.N., Touyer G., Mouren M., Prasad V.V.K., Banner C., Sjövall J., Baulieu E.E., Robel P. Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glans of male and female rats. Endocrinology. 133:1993;1003-1009.
3. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
4. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors dircetly alter activity of neurosteroidogenic enzymes. Proc. Natl. Acad. Sci. USA. 96:1999;13512-13517.
5. Guidotti A., Costa E. Can the antidysphoric and anxiolytic profiles of selective serotonin inhibitors be related to their ability to increase brain 3α,5α-tetrahydroprogesterone (allopregnanolone) availibility? Biol. Psychiatry. 44:1998;865-873.
6. Karavolas H.J., Hodges D. Neuroendocrine metabolism of progesterone and related progestin steroids and neuronal activity. Ciba Foundation Symposium. 153:1990;22-55.
7. A receptor modulators. Am. J. Physiol. 271:1996;E763-E772.
8. Li X., Bertics P.J., Karavolas H.J. Regional distribution of cytosolic and particulate 5alpha-dihydroprogesterone 3alpha-hydroxysteroid oxidoreductases in female rat brain. J. Steroid. Biochem. Molec. Biol. 37:1997;535-543.
9. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 232:1986;1004-1007.
10. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
11. Purdy R.H., Morrow A.L., Moore P.H., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA. 8:1991;4553-4557.
12. Romeo E., Cheney D.L., Zivkovic I., Costa E., Guidotti A. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: Putative role for allopregnanolone. J. Pharmacol. Exp. Ther. 270:1994;89-96.
13. Romeo E., Ströhle A., di Michele F., Spaletta G., Hermann B., Holsboer F., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiat. 155:1998;910-913.
14. Rupprecht R., Reul J.M.H.M., Trapp T., van Steensel B., Wetzel C., Damm K. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 11:1993;523-530.
15. Rupprecht R., Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci. 22:1999;410-416.
16. Ströhle A., Romeo E., Herman B., Pasini A., Spaletta G., di Michelle F., Holsboer F., Rupprecht R. Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiat. 45:1999;274-277.
17. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. USA. 93:1996;12599-12604.
18. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA. 95:1998;3239-3244.